$NXGL

Levy Adam R. sold $2K of NXGL

Levy Adam R. (Chief Executive Officer) sold 3,000 shares of NEXGEL, INC. (NXGL) at $0.60 on 2026-05-29.

Original reporting
SEC EDGAR · Levy Adam R.
Published May 30, 2026, 12:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 30, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXGL
Neutral
medium confidence
Mentioned
$NXGL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXGLNeutralLow
01

Why it matters

The disclosure updates the insider ownership record and may influence short-term sentiment, but it does not introduce new company fundamentals (no earnings, trial, deal, or regulatory action mentioned).

02

Market read

Traders may monitor NXGL for sentiment sensitivity to insider activity, but the disclosed transaction alone is unlikely to drive a major repricing without corroborating catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks details on total insider sales history, option exercises, or broader company catalysts that would contextualize the signal.

Relevance 7/10Novelty 6/10Timing: disclosure filed 2026-05-29 after market close

Background

The article is an SEC Form 4 insider transaction disclosure for NEXGEL (NXGL), reported by CEO Levy Adam R.

Company-level read

Ticker impact

$NXGLNeutralMedium confidence
Context

NEXGEL CEO Levy Adam R. sold 3,000 shares in an open-market transaction disclosed via SEC Form 4 on 2026-05-29.

Expected impact

Low-to-mild negative drift possible around the disclosure; likely limited follow-through absent other catalysts.

Evidence & confidence

The filing is a routine insider transaction with no stated 10b5-1 plan and no accompanying operational/financial update in the article.

Market effects

Minimal sector read-through; single-company insider sale without broader regulatory/product news.

None indicated.

None indicated.

Counterpoint

The sale value is small and may reflect diversification, taxes, or scheduled liquidity needs rather than bearish fundamentals.

Key entities

  • NEXGEL, INC.

    Subject of the Form 4 insider sale; CEO Levy Adam R. sold 3,000 shares at $0.6003/share.

  • Levy Adam R.

    CEO and director who executed the open-market sale; holdings after transaction: 344,692 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NXGLLow

NEXGEL, INC. (NXGL): Results of Operations and Financial Condition

NEXGEL, INC. (NXGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEXGEL Reports Second Quarter 2026 Financial Results LANGHORNE, Pa. – August 17, 2026 – NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content